Global Airway Management Device Market - Industry Trends and Forecast to 2027
- DAT3384261
- 287 Pages
- November 2019
- Healthcare
Market Segmentation:
Type (Supraglottic Airway Management Devices, Laryngoscopes, Infraglottic Airway Management Devices, Resuscitators, Bronchoscope/Intubation Scopes, Others), Patient Ages (Adult, Pediatric Patients/Neonates), Procedure ( Intensive Care Unit or Emergency Procedure, Non-Emergency Surgical Procedures), Application (Anesthesia, Emergency Medicine, Others), End User (Hospitals, Homecare, Ambulatory Surgical Center, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa),Market Trends and Forecast to 2027.
Some of the major factors contributing to the growth of global airway management device market:
• Increasing cases of chronic respiratory diseases
• Increasing incidence of preterm birth Market Players
Market Players
The key market players for global airway management device market are listed below:
• Olympus Corporation
• BD
• ARMSTRONG MEDICAL
• Medline Industries, Inc
• Halma plc
• GENERAL ELECTRIC
• SonarMed
• Mercury Medical
• KARL STORZ
• Smiths Group plc
• Verathon Inc
• VBM Medizintechnik GmbH
• SunMed
• MEDTRONIC
• Flexicare (Group) Limited
• VYAIRE
• Ambu A/S
• Intersurgical Ltd
• Teleflex Incorporated
1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.3 OVERVIEW OF GLOBAL AIRWAY MANAGEMENT DEVICE MARKET 33
1.4 CURRENCY AND PRICING 34
1.5 LIMITATIONS 34
1.6 MARKETS COVERED 35
2 MARKET SEGMENTATION 38
2.1 MARKETS COVERED 38
2.2 GEOGRAPHICAL SCOPE 39
2.3 YEARS CONSIDERED FOR THE STUDY 40
2.4 DBMR TRIPOD DATA VALIDATION MODEL 41
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.6 DBMR MARKET POSITION GRID 45
2.7 DBMR VENDOR SHARE ANALYSIS 46
2.8 MULTIVARIATE MODELING 47
2.9 PRODUCT TIMELINE CURVE 47
2.10 SECONDARY SOURCES 48
2.11 ASSUMPTIONS 48
3 MARKET OVERVIEW 49
3.1 DRIVERS 51
3.1.1 GROWING PREVALENCE OF CHRONIC RESPIRATORY DISEASES 51
3.1.2 HIGH INCIDENCE OF PRETERM BIRTHS 52
3.1.3 INCREASING HEALTHCARE EXPENDITURE 53
3.1.4 REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES 54
3.1.5 INCREASE IN CRITICAL CASES FOR EMERGENCY CARE 55
3.2 RESTRAINTS 57
3.2.1 PRODUCT RECALL OF AIRWAY MANAGEMENT DEVICES 57
3.2.2 HIGH COST ASSOCIATED WITH DEVICES 57
3.3 OPPORTUNITIES 58
3.3.1 STRATEGIC INITIATIVES BY THE COMPANIES 58
3.3.2 TECHNOLOGICAL ADVANCEMENT IN AIRWAY MANAGEMENT DEVICES 59
3.4 CHALLENGES 60
3.4.1 LACK OF SKILLED LABOR FORCE 60
3.4.2 COMPLICATION AND FAILURE ASSOCIATED WITH AIRWAY MANAGEMENT DEVICES 60
4 EXECUTIVE SUMMARY 62
5 PREMIUM INSIGHTS 65
6 GLOBAL AIRWAY MANAGEMENT DEVICES MARKET, BY TYPE 67
6.1 OVERVIEW 68
6.2 SUPRAGLOTTIC AIRWAY MANAGEMENT DEVICES 69
6.2.1 LARYNGEAL MASK AIRWAYS (LMAS) 70
6.2.2 NASOPHARYNGEAL AIRWAYS (NPAS) 70
6.2.3 OROPHARYNGEAL AIRWAYS (OPAS) 70
6.2.4 OTHERS 70
6.3 INFRAGLOTTIC AIRWAY MANAGEMENT DEVICES 71
6.3.1 ENDOTRACHEAL TUBES (ETTS) 71
6.3.2 TRACHEOSTOMY TUBE 71
6.3.3 OTHERS 71
6.4 LARYNGOSCOPES 72
6.4.1 VIDEO LARYNGOSCOPES 72
6.4.1.1 DISPOSABLE 73
6.4.1.2 REUSABLE 73
6.4.2 FIBER OPTIC LARYNGOSCOPE 73
6.4.2.1 DISPOSABLE 73
6.4.2.2 REUSABLE 73
6.5 BRONCHOSCOPE/INTUBATION SCOPES 74
6.5.1.1 DISPOSABLE 74
6.5.1.2 REUSABLE 74
6.6 RESUSCITATORS 75
6.7 OTHERS 75
7 GLOBAL AIRWAY MANAGEMENT DEVICES MARKET, BY PATIENT AGE 76
7.1 OVERVIEW 77
7.2 ADULT 78
7.3 PEDIATRIC PATIENTS/NEONATES 78
8 GLOBAL AIRWAY MANAGEMENT DEVICES MARKET, BY PROCEDURE 79
8.1 OVERVIEW 80
8.2 INTENSIVE CARE UNIT OR EMERGENCY PROCEDURE 81
8.3 NON-EMERGENCY SURGICAL PROCEDURES 81
9 GLOBAL AIRWAY MANAGEMENT DEVICES MARKET, BY APPLICATION 82
9.1 OVERVIEW 83
9.2 ANESTHESIA 84
9.3 EMERGENCY MEDICINE 84
9.4 OTHERS 85
10 GLOBAL AIRWAY MANAGEMENT DEVICES MARKET, BY END USER 86
10.1 OVERVIEW 87
10.2 HOSPITALS 88
10.2.1 INTENSIVE CARE UNITS 88
10.2.2 EMERGENCY CARE DEPARTMENTS 88
10.2.3 OPERATING ROOMS 88
10.2.4 OTHERS 89
10.3 AMBULATORY SURGICAL CENTER (ASCS) 89
10.4 HOMECARE 89
10.5 OTHERS 90
11 GLOBAL AIRWAY MANAGEMENT DEVICES MARKET, BY GEOGRAPHY 91
11.1 OVERVIEW 92
11.2 NORTH AMERICA 97
11.2.1 U.S. 104
11.2.2 CANADA 108
11.2.3 MEXICO 112
11.3 EUROPE 116
11.3.1 GERMANY 123
11.3.2 FRANCE 127
11.3.3 U.K. 131
11.3.4 ITALY 135
11.3.5 SPAIN 139
11.3.6 RUSSIA 143
11.3.7 NETHERLANDS 147
11.3.8 SWITZERLAND 151
11.3.9 BELGIUM 155
11.3.10 TURKEY 159
11.3.11 REST OF EUROPE 163
11.4 ASIA-PACIFIC 164
11.4.1 JAPAN 171
11.4.2 CHINA 175
11.4.3 AUSTRALIA 179
11.4.4 SOUTH KOREA 183
11.4.5 INDIA 187
11.4.6 INDONESIA 191
11.4.7 THAILAND 195
11.4.8 SINGAPORE 199
11.4.9 MALAYSIA 203
11.4.10 PHILIPPINES 207
11.4.11 REST OF ASIA-PACIFIC 211
11.5 SOUTH AMERICA 212
11.5.1 BRAZIL 219
11.5.2 REST OF SOUTH AMERICA 223
11.6 MIDDLE EAST & AFRICA 224
11.6.1 SOUTH AFRICA 231
11.6.2 REST OF MIDDLE EAST & AFRICA 235
12 GLOBAL AIRWAY MANAGEMENT DEVICE MARKET, COMPANY LANDSCAPE 236
12.1 COMPANY SHARE ANALYSIS: GLOBAL 236
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 237
12.3 COMPANY SHARE ANALYSIS: EUROPE 238
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 239
13 COMPANY PROFILE 240
13.1 MEDTRONIC 240
13.1.1 COMPANY SNAPSHOT 240
13.1.2 REVENUE ANALYSIS 240
13.1.3 COMPANY SHARE ANALYSIS 241
13.1.4 PRODUCT PORTFOLIO 241
13.1.5 RECENT DEVELOPMENT 242
13.2 OLYMPUS CORPORATION 243
13.2.1 COMPANY SNAPSHOT 243
13.2.2 REVENUE ANALYSIS 243
13.2.3 COMPANY SHARE ANALYSIS 244
13.2.4 PRODUCT PORTFOLIO 244
13.2.5 RECENT DEVELOPMENT 244
13.3 BD 245
13.3.1 COMPANY SNAPSHOT 245
13.3.2 REVENUE ANALYSIS 245
13.3.3 COMPANY SHARE ANALYSIS 246
13.3.4 PRODUCT PORTFOLIO 246
13.3.5 RECENT DEVELOPMENT 246
13.4 SMITHS GROUP PLC 247
13.4.1 COMPANY SNAPSHOT 247
13.4.2 REVENUE ANALYSIS 247
13.4.3 COMPANY SHARE ANALYSIS 248
13.4.4 PRODUCT PORTFOLIO 248
13.4.5 RECENT DEVELOPMENT 250
13.5 AMBU A/S 251
13.5.1 COMPANY SNAPSHOT 251
13.5.2 REVENUE ANALYSIS 251
13.5.3 PRODUCT PORTFOLIO 252
13.5.4 RECENT DEVELOPMENT 252
13.6 ARMSTRONG MEDICAL 253
13.6.1 COMPANY SNAPSHOT 253
13.6.2 PRODUCT PORTFOLIO 253
13.6.3 RECENT DEVELOPMENT 253
13.7 FLEXICARE (GROUP) LIMITED 254
13.7.1 COMPANY SNAPSHOT 254
13.7.2 PRODUCT PORTFOLIO 254
13.7.3 RECENT DEVELOPMENTS 255
13.8 GENERAL ELECTRIC COMPANY 256
13.8.1 COMPANY SNAPSHOT 256
13.8.2 REVENUE ANALYSIS 256
13.8.3 PRODUCT PORTFOLIO 257
13.8.4 RECENT DEVELOPMENT 257
13.9 INTERSURGICAL LTD 258
13.9.1 COMPANY SNAPSHOT 258
13.9.2 PRODUCT PORTFOLIO 258
13.9.3 RECENT DEVELOPMENT 259
13.10 KARL STORZ SE & CO. KG 260
13.10.1 COMPANY SNAPSHOT 260
13.10.2 PRODUCT PORTFOLIO 260
13.10.3 RECENT DEVELOPMENTS 260
13.11 MEDLINE INDUSTRIES, INC. 261
13.11.1 COMPANY SNAPSHOT 261
13.11.2 PRODUCT PORTFOLIO 261
13.11.3 RECENT DEVELOPMENT 264
13.12 MERCURY MEDICAL 265
13.12.1 COMPANY SNAPSHOT 265
13.12.2 PRODUCT PORTFOLIO 265
13.12.3 RECENT DEVELOPMENTS 266
13.13 RUDOLF RIESTER GMBH (SUBSIDIARY OF HALMA PLC) 267
13.13.1 COMPANY SNAPSHOT 267
13.13.2 REVENUE ANALYSIS 267
13.13.3 PRODUCT PORTFOLIO 268
13.13.4 RECENT DEVELOPMENT 268
13.14 SONARMED 269
13.14.1 COMPANY SNAPSHOT 269
13.14.2 PRODUCT PORTFOLIO 269
13.14.3 RECENT DEVELOPMENTS 269
13.15 SUNMED 270
13.15.1 COMPANY SNAPSHOT 270
13.15.2 PRODUCT PORTFOLIO 270
13.15.3 RECENT DEVELOPMENT 277
13.16 TELEFLEX INCORPORATED 278
13.16.1 COMPANY SNAPSHOT 278
13.16.2 REVENUE ANALYSIS 278
13.16.3 PRODUCT PORTFOLIO 279
13.16.4 RECENT DEVELOPMENTS 280
13.17 VBM MEDIZINTECHNIK GMBH 281
13.17.1 COMPANY SNAPSHOT 281
13.17.2 PRODUCT PORTFOLIO 281
13.17.3 RECENT DEVELOPMENT 281
13.18 VERATHON INC. 282
13.18.1 COMPANY SNAPSHOT 282
13.18.2 PRODUCT PORTFOLIO 282
13.18.3 RECENT DEVELOPMENTS 282
13.19 VYAIRE 284
13.19.1 COMPANY SNAPSHOT 284
13.19.2 SOLUTION PORTFOLIO 284
13.19.3 RECENT DEVELOPMENT 284
14 QUESTIONNAIRE 285
15 RELATED REPORTS 287
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
